Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 1796 results found since Jan 2013.
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
Open Forum Infect Dis. 2022 Oct 23;9(10):ofac485. doi: 10.1093/ofid/ofac485. eCollection 2022 Oct.ABSTRACTApproximately 10 years after vaccination with the recombinant zoster vaccine (RZV), an interim analysis of this follow-up study of the ZOE-50/70 trials demonstrated that efficacy against herpes zoster remained high. Moreover, the safety profile remained clinically acceptable, suggesting that the clinical benefit of the RZV in ≥50-year-olds is sustained up to 10 years.PMID:36299530 | PMC:PMC9588150 | DOI:10.1093/ofid/ofac485
Source: Herpes - October 27, 2022 Category: Infectious Diseases Authors: Ana Strezova Javier Diez-Domingo Kamal Al Shawafi Juan Carlos Tinoco Meng Shi Paola Pirrotta Agnes Mwakingwe-Omari Zoster-049 Study Group Source Type: research
Examples of Outcome Reporting Bias in Vaccine Studies: Illustrating How Perpetuating Medical Consensus Can Impede Progress in Public Health
CONCLUSIONS: Conflicts of interest (e.g., financial) that abound between health regulatory agencies and the pharmaceutical industry impact what is ultimately reckoned as medical consensus. Outcome reporting bias that is inherent to all researchers to some degree, obscures medical and scientific truth. Advancement of public health requires that researchers have integrity and an openness and willingness to collaborate to resolve contradictory findings. In fact, it is usually through meticulous, rigorous, scientific investigation of contradictory findings that medical science has advanced and contributed to improvements in pu...
Source: Herpes - October 28, 2022 Category: Infectious Diseases Authors: Gary S Goldman Source Type: research
Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia: illustrative case
J Neurosurg Case Lessons. 2022 Apr 18;3(16):CASE22101. doi: 10.3171/CASE22101. Print 2022 Apr 18.ABSTRACTBACKGROUND: Vaccines against coronavirus disease 2019 have a high level of efficacy and safety across all populations. However, numerous case series have been published on neurological disorders, including Bell's palsy, Guillain-Barre syndrome, transverse myelitis, and multiple sclerosis. The authors presented a case of trigeminal neuropathy after coronavirus vaccination in a patient who had undergone microvascular decompression (MVD) for trigeminal neuralgia (TN).OBSERVATIONS: A 77-year-old woman presented with acute t...
Source: Herpes - October 28, 2022 Category: Infectious Diseases Authors: Keisuke Onoda Ryohei Sashida Ren Fujiwara Tomihiro Wakamiya Yuhei Michiwaki Tatsuya Tanaka Kazuaki Shimoji Eiichi Suehiro Fumitaka Yamane Masatou Kawashima Akira Matsuno Source Type: research
The Awareness and Attitude of Physicians to Older Adult Routine Vaccination Scheme
CONCLUSION: Awareness of routine vaccination schedules should be improved among health-care professionals, and reminders for immunization should be provided periodically in each health-care setting.PMID:36338873 | PMC:PMC9635550 | DOI:10.2147/CIA.S382311
Source: Herpes - November 7, 2022 Category: Infectious Diseases Authors: Esra Ates Bulut Suade Ozlem Badak Huseyin Aksoy Ayse Fadiloglu Ahmet Turan Isik Source Type: research
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
CONCLUSION: Although our follow-up period is relatively short, the safety data we reported are reassuring. This data would help to contrast the vaccine hesitancy often manifested by patients with IEI and to better inform their healthcare providers.PMID:36374363 | PMC:PMC9662105 | DOI:10.1007/s10875-022-01402-6
Source: Herpes - November 14, 2022 Category: Infectious Diseases Authors: Cinzia Milito Francesco Cinetto Giulia Garzi Andrea Palladino Marco Puca Elena Brambilla Camilla De Vitis Giulia Costanzo Riccardo Scarpa Alessandra Punziano Gianluca Lagnese Stefano Del Giacco Giuseppe Spadaro Isabella Quinti Davide Firinu Source Type: research
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
Viruses. 2022 Nov 29;14(12):2667. doi: 10.3390/v14122667.ABSTRACTInfection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or "chickenpox", or it can reactivate later in life and cause herpes zoster or "shingles". Herpes zoster mainly occurs in older adults, causing a reduction in activities of daily living, impacting quality of life, and may lead to serious complications, including chronic pain. Two vaccines are marketed to prevent herpes zoster: the live zoster vaccine and the non-live, recombinant zoster vaccine. The pre-licensure clinical trials show the efficacy of...
Source: Herpes - December 23, 2022 Category: Infectious Diseases Authors: Yasmin Marra Fawziah Lalji Source Type: research
Clinical and epidemiological aspects of herpes zoster disease in a primary care setting in Riyadh, Saudi Arabia: A retrospective cohort study
CONCLUSIONS: Zoster vaccination uptake was low. A national program for adult vaccination, including zoster vaccination, should be developed, and a guideline to direct primary health-care professionals in the management of HZ infections should be implemented.PMID:36618136 | PMC:PMC9810876 | DOI:10.4103/jfmpc.jfmpc_933_22
Source: Herpes - January 9, 2023 Category: Infectious Diseases Authors: Abdullah S Binsaeedu Abubakr O Bajaber Aiman G Muqrad Yaser A Alendijani Hamad A Alkhenizan Thamer A Alsulaiman Abdullah H Alkhenizan Source Type: research
Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population
CONCLUSIONS: Older adults were generally more willing to get vaccinated against influenza than for the three less familiar diseases. Characteristics of those less willing may be used to improve strategies to increase vaccination coverage. Additional studies are needed to investigate the willingness to get vaccinated during and after the COVID-19 pandemic that may have changed the feel of urgency for vaccination.PMID:36639273 | PMC:PMC9810548 | DOI:10.1016/j.vaccine.2023.01.001
Source: Vaccine - January 13, 2023 Category: Allergy & Immunology Authors: K M Maertzdorf M L Rietman M S Lambooij W M M Verschuren H S J Picavet Source Type: research
Licensed liposomal vaccines and adjuvants in the antigen delivery system
BioTechnologia (Pozn). 2022 Dec 24;103(4):409-423. doi: 10.5114/bta.2022.120709. eCollection 2022.ABSTRACTLiposomes (LSs) are promising nanoparticles with unique properties such as controlled nanosize, large surface area, increased reactivity, and ability to undergo modification. Worldwide, licensed liposomal forms of antibiotics, hormones, antioxidants, cytostatics, ophthalmic drugs, etc., are available on the pharmaceutical market. This review focuses on the adjuvant properties of LSs in the production of vaccines (VACs). LS-VACs have the following advantages: antigens with low immunogenicity can become highly immunogeni...
Source: Herpes - January 23, 2023 Category: Infectious Diseases Authors: Yuriy Krasnopolsky Daria Pylypenko Source Type: research
